| 注册
首页|期刊导航|中国医院用药评价与分析|氯吡格雷联合阿托伐他汀对冠心病心绞痛患者纤溶状态及心功能的影响

氯吡格雷联合阿托伐他汀对冠心病心绞痛患者纤溶状态及心功能的影响

王永虎 曲志培

中国医院用药评价与分析2019,Vol.19Issue(2):197-199,3.
中国医院用药评价与分析2019,Vol.19Issue(2):197-199,3.DOI:10.14009/j.issn.1672-2124.2019.02.025

氯吡格雷联合阿托伐他汀对冠心病心绞痛患者纤溶状态及心功能的影响

Effects of Clopidogrel Combined with Atorvastatin on Fibrinolysis Status and Cardiac Function in Patients with Angina Pectoris of Coronary Heart Disease

王永虎 1曲志培1

作者信息

  • 1. 河南省唐河县人民医院内二科, 河南 唐河 473400
  • 折叠

摘要

Abstract

OBJECTIVE: To probe into the effects of clopidogrel combined with atorvastatin on fibrinolysis status and cardiac function in patients with angina pectoris of coronary heart disease (CHD). METHODS: Totally 116 patients with angina pectoris of CHD admitted into Henan Tanghe County People's Hospital from Oct. 2016 to Oct. 2017 were extracted to be divided into observation group and control group via the random number table, with 58 cases in each group. Patients in the control group were given conventional drug therapy, while the observation group received clopidogrel and atorvastatin on the basis of the control group. The clinical efficacy, number and duration of angina attacks, tissue plasminogen activator inhibitor 1 (tPAI-1), soluble E-selectin (sE-selectin), ejection fraction (EF), cardiac index (CI) before and after treatment and adverse drug reactions were observed. RESULTS: The total effective rate of the observation group was 93.10% (54/58), significantly higher than that of the control group (77.59%, 45/58), with statistically significant difference (P<0.05). After treatment, the number and duration of angina attacks in the observation group were significantly better than those in the control group, with statistically significant differences (P<0.05). After treatment, the tPAI-1 and sE-selectin levels in the observation group were significantly lower than those in the control group, and the EF and CI levels were significantly higher than those in the control group, with statistically significant differences (P<0.05). The incidence of adverse drug reactions in the observation group and the control group was 5.17% (3/58) and 8.62% (5/58), respectively, with no statistically significant difference (P>0.05). CONCLUSIONS: The efficacy of clopidogrel combined with atorvastatin in treatment of angina pectoris of CHD is remarkable, which can correct the symptoms of angina pectoris, help to regulate the state of fibrinolysis and improve the heart function with higher safety.

关键词

冠心病心绞痛/氯吡格雷/阿托伐他汀/纤溶状态/心功能

Key words

Angina pectoris of coronary heart disease/Clopidogrel/Atorvastatin/Fibrinolysis status/Cardiac function

分类

医药卫生

引用本文复制引用

王永虎,曲志培..氯吡格雷联合阿托伐他汀对冠心病心绞痛患者纤溶状态及心功能的影响[J].中国医院用药评价与分析,2019,19(2):197-199,3.

中国医院用药评价与分析

OACSTPCD

1672-2124

访问量8
|
下载量0
段落导航相关论文